(Q40097562)

17 September 2017

1 reference

title

Central monoamine metabolism in depressions. I. Serotonin and related compounds (English)

1 reference

17 September 2017

H. M. van Praag

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6153593

16 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6153593

16 August 2023

publication date

1 January 1980

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0010440X80900620?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

https://api.elsevier.com/content/article/PII:0010440X80900620?httpAccept=text/plain

16 August 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

16 August 2023

published in

Comprehensive Psychiatry

1 reference

17 September 2017

21

1 reference

17 September 2017

1

1 reference

17 September 2017

30-43

1 reference

Neuroendocrine disorders in depressions and their significance for the monoamine hypothesis of depression

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Enhancement of central norepinephrine and 5-hydroxytryptamine transmission by tricyclic antidepressants

16 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Clinical approaches to the evaluation of brain amine function in mental illness: some conceptual issues

16 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients

16 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Biochemical post-mortem findings in depressed patients

16 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

16 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients

16 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

16 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Cerebral monoamines and depression. An investigation with the Probenecid technique.

16 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

The position of biological psychiatry among the psychiatric disciplines

16 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Brain serotonin content: physiological dependence on plasma tryptophan levels.

16 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Free tryptophan in plasma and brain tryptophan metabolism.

16 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Relationship between mood disturbances and free and total plasma tryptophan in postpartum women

16 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Mood changes in puerperium, and plasma tryptophan and cortisol concentrations

16 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan

16 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Tryptophan and depressive illness

16 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

A clinical and biochemical study of a trial of iproniazid in the treatment of depression

16 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Tryptophan antidepressant ?physiological sedative?: Fact or fancy?

16 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Comparative trial of L-tryptophan and amitriptyline in depressive illness

16 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Potentiation of the antidepressant action of clomipramine by tryptophan

16 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with 'therapy-resistant' depressions.

16 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Clinical Evaluation of 5-Hydroxy-L-Tryptophan as an Antidepressant Drug

16 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled study

16 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Letter: L 5-Hydroxytryptophan and mood

16 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Intravenous L-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Part 1: Implications of reproducible mood elevation

16 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

16 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Preliminary clinical test of zimelidine (H 102/09), a new 5-HT uptake inhibitor

16 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

CENTRAL SEROTONIN DEFICIENCY-A FACTOR WHICH INCREASES DEPRESSION VULNERABILITY?

16 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Psychopsychiatry: Can psychosocial factors cause psychiatric disorders?

16 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity

16 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients

16 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy

16 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline

16 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Endorphins and their significance for psychopathology

16 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE)

16 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant

16 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0010-440X(80)90062-0

16 August 2023

Identifiers

1 reference

17 September 2017

1 reference